Financial statements Sciencepharma

Balance sheet of Sciencepharma

Company age:
Age:
3 y. 9 m. 8 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of SCIENCEPHARMA

Year
2021
2022
2023
Total assets 192 024 202,70 248 731 273,26 235 042 686,57
A. Fixed assets 90 903,87 157 842,37 1 632 227,36
B. Current assets 191 933 298,83 248 573 430,89 233 410 459,21
C. Share capital contributions (basic funds) - - -
D. Own shares (stocks) - - -
Total liabilities 192 024 202,70 248 731 273,26 235 042 686,57
A. Equity 17 275 468,88 22 698 169,91 37 936 347,28
B. Liabilities and provisions for liabilities 174 748 733,82 226 033 103,35 197 106 339,29
I. Long-term liabilities 444 900,26 0,00 0,00
II. Short-term liabilities 174 276 916,56 225 942 376,35 197 091 193,79
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.